Literature DB >> 26472613

Preparation and characterization of pro-angiogenic gel derived from small intestinal submucosa.

Wei Wang1, Xia Zhang1, Ning-Ning Chao1, Ting-Wu Qin1, Wei Ding1, Yi Zhang1, Jiang-Wei Sang1, Jing-Cong Luo2.   

Abstract

Gels derived from decellularized small intestinal submucosa (SIS) have been used to repair ischemic myocardium and deliver protein drug. However, their material properties and effects on cell behavior are not well understood, in part because of the difficulty of gelling in vitro. In this study, soluble SIS matrix, which was easily handled and could effectively gel, was successfully prepared using a modified method. Fourier transform infrared spectroscopy confirmed that the SIS gel contained not only collagen but also sulfated glycosaminoglycans (sGAGs). Interestingly, the sustained release of vascular endothelial growth factor and basic fibroblast growth factor within the SIS gel was detected, and no initial burst release was observed. The SIS gel was more capable of evoking neovascularization than collagen type I gel, as determined by tube formation experiments in human umbilical vein endothelial cells, the mouse aortic ring assay, and animal experiments. The upregulated expression of kinase insert domain receptor (KDR), Notch1, and Ang2, the key genes in angiogenesis that were evaluated in HUVECs seeded on the SIS gel, confirmed that angiogenesis bioactive factors contained in the SIS gel are indeed active and effective. The SIS gel significantly promoted neovascularization compared to the collagen type I gel in vivo. Histology revealed adequate host tissue response in engraftment both types of gels. Together, these data demonstrate that the SIS gel is a promising and attractive candidate for tissue engineering, especially in promoting vessel formation. STATEMENT OF SIGNIFICANCE: The material properties of small intestinal submucosa (SIS) gel and the effect of these properties upon cell behavior are not well understood, in part due to the difficulty of gelling in vitro. In this study, soluble SIS matrix, which was easily handled and gelled was prepared using modified method. The material properties and biocompatibility of SIS gel were explored. The sustained release of growth factors from this gel was observed along with its degradation in vitro. The results demonstrate that the SIS gel promote angiogenesis in vitro and in vivo. The SIS gel biological properties suggest that the constituent ECM molecules released from the gel remain activity. These findings suggested that the SIS gel was a promising candidate for tissue engineering, especially in promoting vessel formation.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Biocompatibility; Gel; Growth factor; Small intestinal submucosa

Mesh:

Substances:

Year:  2015        PMID: 26472613     DOI: 10.1016/j.actbio.2015.10.013

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  17 in total

Review 1.  Extracellular matrix hydrogel therapies: In vivo applications and development.

Authors:  Martin T Spang; Karen L Christman
Journal:  Acta Biomater       Date:  2017-12-20       Impact factor: 8.947

2.  Vascularization in tissue engineering: fundamentals and state-of-art.

Authors:  Guang Yang; Bhushan Mahadik; Ji Young Choi; John P Fisher
Journal:  Prog Biomed Eng (Bristol)       Date:  2020-01-09

3.  Perivascular extracellular matrix hydrogels mimic native matrix microarchitecture and promote angiogenesis via basic fibroblast growth factor.

Authors:  George R Fercana; Saigopalakrishna Yerneni; Marie Billaud; Jennifer C Hill; Paul VanRyzin; Tara D Richards; Brian M Sicari; Scott A Johnson; Stephen F Badylak; Phil G Campbell; Thomas G Gleason; Julie A Phillippi
Journal:  Biomaterials       Date:  2017-01-30       Impact factor: 12.479

4.  Creation of Bony Microenvironment with Extracellular Matrix Doped-Bioactive Ceramics to Enhance Osteoblast Behavior and Delivery of Aspartic Acid-Modified BMP-2 Peptides.

Authors:  Jinge Zhou; Zekang Xiong; Man Liu; Liang Yang; Sheng Yao; Kaifang Chen; Keda Yu; Yanzhen Qu; Tingfang Sun; Xiaodong Guo
Journal:  Int J Nanomedicine       Date:  2020-10-29

5.  Enhancement of Migration and Tenogenic Differentiation of Macaca Mulatta Tendon-Derived Stem Cells by Decellularized Tendon Hydrogel.

Authors:  Liang-Ju Ning; Ya-Jing Zhang; Yan-Jing Zhang; Min Zhu; Wei Ding; Yan-Lin Jiang; Yi Zhang; Jing-Cong Luo; Ting-Wu Qin
Journal:  Front Cell Dev Biol       Date:  2021-04-27

6.  The effects of bone marrow stem and progenitor cell seeding on urinary bladder tissue regeneration.

Authors:  Matthew I Bury; Natalie J Fuller; Renea M Sturm; Rebecca R Rabizadeh; Bonnie G Nolan; Milica Barac; Sonia S Edassery; Yvonne Y Chan; Arun K Sharma
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

7.  Accelerating ESD-induced gastric ulcer healing using a pH-responsive polyurethane/small intestinal submucosa hydrogel delivered by endoscopic catheter.

Authors:  Long-Mei Zhao; Mei Gong; Rui Wang; Qi-Juan Yuan; Yi Zhang; Jin-Kui Pi; Xiu-He Lv; Yan Xie; Hui-Qi Xie
Journal:  Regen Biomater       Date:  2021-01-04

Review 8.  Sterilization and disinfection methods for decellularized matrix materials: Review, consideration and proposal.

Authors:  Meihan Tao; Tianrang Ao; Xiaoyan Mao; Xinzhu Yan; Rabia Javed; Weijian Hou; Yang Wang; Cong Sun; Shuang Lin; Tianhao Yu; Qiang Ao
Journal:  Bioact Mater       Date:  2021-02-27

Review 9.  Progress in development of bioderived materials for dermal wound healing.

Authors:  Lin-Cui Da; Yi-Zhou Huang; Hui-Qi Xie
Journal:  Regen Biomater       Date:  2017-10-09

10.  Preparation and characterization of amnion hydrogel and its synergistic effect with adipose derived stem cells towards IL1β activated chondrocytes.

Authors:  Maumita Bhattacharjee; Jorge L Escobar Ivirico; Ho-Man Kan; Rosalie Bordett; Rishikesh Pandey; Takayoshi Otsuka; Lakshmi S Nair; Cato T Laurencin
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.